Transcatheter aortic valve replacement with balloon-expandable and self-expandable valves in Japanese patients with large annulus: the OCEAN-TAVI registry
Abstract Background East Asians have smaller aortic valve complexes than individuals from Western countries, and few studies have reported transcatheter aortic valve replacement (TAVR) outcomes in Asian patients with a large annulus. Purpose We aimed to compare the acute and long-term outcomes of TAVR using balloon-expandable valves (BEVs) and self-expandable valves (SEVs) in Asian patients with a large annulus. Methods We retrospectively analyzed the data from the Optimized transCathEter vAlvular interveNtion Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry. A large annulus was defined by annular area ≥ 500 mm2 and average diameter ≥ 25 mm in computed tomography scans. The primary endpoint was the 3-year all-cause mortality. Secondary endpoints were 3-year heart-failure rehospitalization (HFR) after TAVR, acute outcomes of TAVR, and changes in valve function on echocardiography 2 years after TAVR. Results Among 773 patients, 671 (86.8%) underwent BEV-TAVR. The SEV-TAVR group showed a significantly higher incidence of above-moderate perivalvular leakage (2.1% vs. 7.8%; P < 0.001), and included a significantly greater percentage of patients who required postoperative pacemaker implantation (6.1% vs. 11.8%; P = 0.035). The incidence of moderate-to-severe prosthesis–patient mismatch did not differ between the two groups. The Kaplan–Meier curve showed no significant intergroup differences in the 3-year all-cause mortality and HFR rates (log-rank P = 0.900), and the echocardiography-indexed effective orifice area and mean transaortic valve pressure gradient at 2 years post-TAVR did not differ significantly between the two groups. Conclusions The benefits of BEV-TAVR may outweigh those of SEV-TAVR in patients with a large annulus.
Authors
- Naoko Soejima
- Fumiaki Yashima (ORCID: https://orcid.org/0000-0002-7755-5771)
- Masanori Yamamoto (ORCID: https://orcid.org/0000-0001-5210-6382)
- Hiroki Matsuzoe (ORCID: https://orcid.org/0000-0002-9180-1334)
- Kosuke Fujita (ORCID: https://orcid.org/0000-0001-7277-5209)
- Kentaro Hayashida (ORCID: https://orcid.org/0000-0002-1750-1982)
- Gaku Nakazawa (ORCID: https://orcid.org/0000-0002-6721-1342)
- Kazuki Mizutani (ORCID: https://orcid.org/0000-0001-7206-4538)
- Akira Yoshida (ORCID: https://orcid.org/0000-0003-0280-9674)
- Genichi Sakaguchi
- K Onishi (ORCID: https://orcid.org/0009-0005-2807-2916)
- Masafumi Ueno (ORCID: https://orcid.org/0000-0002-3613-660X)
- N Yamada
Institutions
- Keio University (JP)
- Kindai University Hospital (JP)
- Saiseikai Utsunomiya hospital (JP)
- Toyohashi Heart Center (JP)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/eurheartj/ehae666.2442
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00